Verified Document

Johnson And Johnson Employees Term Paper

JNJ The 2011 Annual Report does not explicitly outline Johnson & Johnson's executive compensation agreements.

The company does report in general terms on its options plans. This report is found in page 54 of the 2011 Annual Report, under Section 17. The options details are as follows:

Stock Options

Stock options expire 10 years from the date of grant and vest over service periods that range from six months to four years. All options are granted at the average of the high and low prices of the Company's Common Stock on the New York Stock Exchange on the date of grant. Under the 2005 Long-Term Incentive Plan, the Company may issue up to 260 million shares of common stock. Shares available for future grants under the 2005 Long-Term Incentive Plan were 104.9million at the end of 2011. The Company settles employee stock option exercises with treasury shares. Treasury shares are replenished throughout the year for the number...

The fair value of each option award was estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following table. Expected volatility represents a blended rate of 4-year daily historical average volatility rate, and a 5-week average implied volatility rate based on at -- the money traded Johnson & Johnson options with a life of 2 years. Historical data is used to determine the expected life of the option. The risk-free rate was based on the U.S. Treasury yield curve in effect at the time of grant. The average fair value of options granted was $7.47, $8.03 and $8.35, in 2011, 2010, and 2009, respectively. The fair value was estimated based on the weighted average assumptions of:
2011 2010 2009

Risk-free rate 2.41% 2.78% 2.71%

Expected volatility 18.2% 17.4% 19.5%

Expected life 6.0 yrs 6.0 yrs 6.0…

Sources used in this document:
Resources; Alex Gorsky is the Vice-Chairman of the Executive Committee; Sherilyn McCoy is another Vice-Chairman of the Executive Committee and Michael Ullmann is the General Counsel.

6. Johnson & Johnson does not publish an organizational chart. The company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices (p.26). There are geographical and product subdivisions within these broad three business units.
Cite this Document:
Copy Bibliography Citation

Related Documents

Johnson and Johnson Corporation
Words: 2199 Length: 7 Document Type: Term Paper

Johnson & Johnson Corporation Johnson and Johnson has been a very broadly-based organization that has been manufacturing health care products since a very long time. It started its footsteps as a child in the mid 1880s with the production of ready-to-use, ready-made surgical dressing. It was the first company to have applied the theory of wound treatment by use of antiseptics. With its application, the chances of infection in postoperative patients

Johnson and Johnson Annual Report Review Financial
Words: 1743 Length: 6 Document Type: Case Study

Johnson and Johnson Annual Report Review Financial Report Review Company: Johnson and Johnson Consolidated Balance Sheets Total Assets: $121,347,000,000 Total Liabilities: $56,521,000,000 Total Shareholder's Equity: $64,826,000,000 Company's Retained Earnings: 85,992,000,000 Shares of common stock the company has been authorized to issue: 4,320,000,000 shares Shares the company has issued: 3,119,843,000 shares Cash (cash and cash equivalents): $14,911,000,000 Decrease in cash and cash equivalents during 2012: $9,631,000,000 F: Increase in cash and cash equivalents during 2011: $5,187,000 Consolidated Statement of Earnings Essentially, the term "consolidated" as used

Johnson Bank V. George Korbaken Company Johnson
Words: 2964 Length: 10 Document Type: Essay

Johnson Bank v. George Korbaken Company Johnson Bank v. George Korbakes Company Over the last several years, the role of the auditor has been continually evolving. This is because financial institutions are relying on the information they are provided with to help them make better choices in the long-term. However, there are times when these firms may not have accurate figures and erroneously report their findings. When this happens, there is a

Johnson and Johnson & Johnson J&j Johnson
Words: 1039 Length: 4 Document Type: Essay

Johnson and Johnson Johnson & Johnson (J&J) Johnson & Johnson (J&J) is the eighth largest pharmaceutical company, sixth largest consumer health care company and the largest seller of medical devices across the globe. It has provided a period of care to its consumers for more than 120 years (1886-2012) and therefore it is a brand that is very famous and well recognized by people in all parts of the world. Johnson &

Johnson Drug Company Needs to
Words: 1347 Length: 5 Document Type: Research Proposal

So every often, the retailer would be aware of other similar products in the market and if client brings up other products, the sales people should know why their product is better. This can only happen if they know of other products. Even though the training program would be an additional financial burden, still the rewards and benefits can be enormous. In the light of what it can do for

Johnson and Johnson Internet
Words: 648 Length: 2 Document Type: Term Paper

Johnson & Johnson Internet When most people think of Johnson & Johnson, they will often associate it with the various pharmaceutical related businesses. This is a dramatic reduction in the size of the company from what it once was a few years ago. The reasons why is from globalization and bureaucracy forcing the company to seek out ways to reduce their underlying costs. To fully understand how this is taking place

Sign Up for Unlimited Study Help

Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.

Get Started Now